1. Home
  2. TMDX vs GRBK Comparison

TMDX vs GRBK Comparison

Compare TMDX & GRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • GRBK
  • Stock Information
  • Founded
  • TMDX 1998
  • GRBK 2006
  • Country
  • TMDX United States
  • GRBK United States
  • Employees
  • TMDX N/A
  • GRBK N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GRBK Homebuilding
  • Sector
  • TMDX Health Care
  • GRBK Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • GRBK Nasdaq
  • Market Cap
  • TMDX 4.8B
  • GRBK 2.6B
  • IPO Year
  • TMDX 2019
  • GRBK N/A
  • Fundamental
  • Price
  • TMDX $128.97
  • GRBK $65.64
  • Analyst Decision
  • TMDX Buy
  • GRBK Buy
  • Analyst Count
  • TMDX 10
  • GRBK 2
  • Target Price
  • TMDX $127.33
  • GRBK $71.00
  • AVG Volume (30 Days)
  • TMDX 838.7K
  • GRBK 245.9K
  • Earning Date
  • TMDX 07-30-2025
  • GRBK 07-30-2025
  • Dividend Yield
  • TMDX N/A
  • GRBK N/A
  • EPS Growth
  • TMDX N/A
  • GRBK 26.03
  • EPS
  • TMDX 1.41
  • GRBK 8.31
  • Revenue
  • TMDX $488,227,000.00
  • GRBK $2,149,226,000.00
  • Revenue This Year
  • TMDX $34.07
  • GRBK N/A
  • Revenue Next Year
  • TMDX $20.76
  • GRBK $9.93
  • P/E Ratio
  • TMDX $92.35
  • GRBK $7.84
  • Revenue Growth
  • TMDX 64.43
  • GRBK 21.22
  • 52 Week Low
  • TMDX $55.00
  • GRBK $50.57
  • 52 Week High
  • TMDX $177.37
  • GRBK $84.66
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 59.35
  • GRBK 57.73
  • Support Level
  • TMDX $120.36
  • GRBK $61.95
  • Resistance Level
  • TMDX $133.49
  • GRBK $64.26
  • Average True Range (ATR)
  • TMDX 5.58
  • GRBK 1.93
  • MACD
  • TMDX -1.35
  • GRBK 0.24
  • Stochastic Oscillator
  • TMDX 60.26
  • GRBK 67.45

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title.

Share on Social Networks: